Coverage
-
March 18, 2022
A D.C. federal judge on Friday put an end to LabMD's lawsuit accusing three Federal Trade Commission lawyers of launching a retaliatory investigation and crippling the cancer research company after its CEO criticized them, saying there was no basis to reopen the case after the D.C. Circuit ruled in favor of the FTC investigators.
2 other articles on this case.
View all »